Alzheimer's disease: Clinical aspects and treatments

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Volumn , Issue , 2014, Pages 17-26

  Ghezzi, Laura ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Alzheimer's disease; Biomarkers; Neurodegeneration

Indexed keywords

EID: 84930599486     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4471-6380-0_2     Document Type: Chapter

References (22)

1. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: A Delphi consensus study. Lancet. 2005;366:2112-7.
2. Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol. 2011;7(3):137-52.
3. Ritchie K, Lovestone S. The dementias. Lancet. 2002;360:1759-66.
4. Galimberti D, Scarpini E, Ghezzi L. Immunotherapy against amyloid pathology in Alzheimer's disease. J Neurol Sci. 2013;333(1-2):50-4.
5. Apostolova LG, Cummings JL. Neuropsychiatric manifestations in mild cognitive impairment: A systematic review of the literature. Dement Geriatr Cogn Disord. 2008;25:115-26.
6. Arnaiz E, Almkvist O. Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease. Acta Neurol Scand. 2003;179(Suppl):34-41.
7. Fitzpatrick AL, Kuller LH, Lopez OL, Kawas CH, Jagust W. Survival following dementia onset: Alzheimer's disease and vascular dementia. J Neurol Sci. 2005;229:43-9.
8. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, et al. Revising the defi nition of Alzheimer's disease: A new lexicon. Lancet Neurol. 2010;9(11): 1118-27.
9. Petersen RC, Roberts RO, Knopman DS, et al. Mild cognitive impairment: Ten years later. Arch Neurol. 2009;66(12):1447-55.
10. McKhann G, Drachman DA, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939-44.
11. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6:734-46.
12. Hort J, O'Brien JT, Gainotti G, Pirttili T, Popescu BO, Rektorova I, et al. EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol. 2010;17(10):1236-48.
13. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (IVTR). 4th ed, text revised. Washington, DC: American Psychiatric Association; 2000.
14. Bartus RT, Dean III RL, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science. 1982;217:408-14.
15. Knowles J. Donepezil in Alzheimer's disease: An evidence-based review of its impact on clinical and economic outcomes. Core Evid. 2006;1(3):195-219.
16. Courtney C, Farrell D, Gray R, Hills R, Lynch L, Sellwood E, et al. AD2000 Collaborative Group. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet. 2004;363:2105-15.
17. Birks J, Evans JG, Iakovidou V, Tsolaki M. Rivastigmine for Alzheimer's disease. Cochrane Database Syst Rev. 2009;2, CD001191.
18. Qaseem A, Snow V, Cross Jr TJ, Forciea MA, Hopkins Jr. R, Shekelle P, et al. Current pharmacologic treatment of dementia: A clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2008; 148:370-8.
19. Crutch SJ, Lehmann M, Schott JM, Rabinovici GD, Rossor MN, Fox NC. Posterior cortical atrophy. Lancet Neurol. 2012;11:170-8.
20. Mendez MF, Ghajarania M, Perryman KM. Posterior cortical atrophy: clinical characteristics and differences compared to Alzheimer's disease. Dement Geriatr Cogn Disord. 2002;14:33-40.
21. Tang-Wai DF, Graff-Radford NR, Boeve BF, Dickson DW, Parisi JE, Crook R, et al. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology. 2004;63:1168-74.
22. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classifi cation of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006-14.